Immunization needs of chronic liver disease patients seen in primary care versus specialist settings

Digestive Diseases and Sciences

Volumn 50, Issue 8, 2005, Pages 1525-1531

  Jacobs, R Jake ^a   Meyerhoff, Allen S ^a   Saab, Sammy ^a  

^a Capitol Outcomes Research Inc   (United States)

Author keywords

Hepatitis A vaccine; Hepatitis B vaccine; Immunizations; Influenza vaccine; Liver diseases; Pneumococcal vaccine

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ADULT; ARTICLE; CAUCASIAN; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; HEALTH CARE POLICY; HEALTH CENTER; HEALTH INSURANCE; HEPATITIS C; HUMAN; IMMUNIZATION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL SPECIALIST; PATIENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SEROLOGY; VACCINATION;

ADULT; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; GASTROENTEROLOGY; HEPATITIS A VACCINES; HEPATITIS B VACCINES; HUMANS; INFLUENZA VACCINES; LIVER DISEASES; MALE; MIDDLE AGED; NEEDS ASSESSMENT; PNEUMOCOCCAL VACCINES; PRIMARY HEALTH CARE; VACCINATION;

EID: 22844444686     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2873-5     Document Type: Article

References (38)

1. Centers for Disease Control: Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 48(RR12):1-37, 1999
2. National Institutes of Health: Consensus Development Conference Statement: Management of hepatitis C. Available at: http://www.liverfoundation. org/images/advocacy/1015/nih.final.rev.pdf. Accessed January 2004
3. American College of Gastroenterology: Chronic liver disease: a primer for vaccination. Available at: http://www.acg.gi.org/physicianforum/publications/ CLDPrimer/cld.pdf. Accessed January 2004
4. Centers for Disease Control: Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 46(RR 8):1-32, 1997
5. Vento S, Garofano T, Renzini C, Cainelli F, Casali F, Ghironzi G, Ferraro T, Concia E: Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 338:286-290, 1998
6. Datta D, Williams I, Culver D, Bloom SC, Bell BP: Association between deaths due to hepatitis A and chronic liver disease, United States, 1981-1997. Antiviral Ther 5 (Suppl 1):79-80, 2000 (abstract)
7. Benvegnu L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cecchetto A, Alberti A: Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 74:2442-2448, 1994
8. Kew MC, Yu MC, Kedda MA, Coppin A, Sarkin A, Hodkinson J: The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in Southern African blacks. Gastroenterology 112:184-187, 1997
9. Alberti A, Pontisso P, Chemello L, Fattovich G, Benvegnu L, Belussi F, De Mitri MS: The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease. J Hepatol 22(Suppl 1):38-41, 1995
10. Keeffe EB: Vaccination against hepatitis A and B in chronic liver disease. Viral Hepatitis Rev 5:77-88, 1999
11. Ramos RJM, Cuenca EM, Fernandez GML: Retrospective and comparative study of pneumococcal bacteremia in patients with chronic hepatopathy. An Med Intera 13:313-316, 1996
12. Centers for Disease Control: Prevention of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 49(RR-3):1-38, 2000
13. Arguedas, MR, McGuire BM, Fallon MB: Implementation of vaccination in patients with cirrhosis. Dig Dis Sci 47:384-387, 2002
14. Rothstein KD: Hepatitis A vaccination in patients with chronic liver disease: to screen or not to screen? Am J Gastroenterol 97:1590-1593, 2002
15. Sjögren MH: Preventing acute liver disease in patients with chronic liver disease. Hepatology 27:887-888, 1998
16. Duncan M, Hirota WK, Tsuchida A: Prescreening versus empirical immunization for hepatitis A in patients with chronic liver disease: a prospective cost analysis. Am J Gastroenterol 97:1792-1795, 2002
17. Siddiqui F, Mutchnick M, Kinzie J, Peleman R, Naylor P, Ehrinpreis M: Prevalence of hepatitis A virus and hepatitis B virus immunity in patients with polymerase chain reaction-confirmed hepatitis C: implications for vaccination strategy. Am J Gastroenterol 96:858-863, 2001
18. Stokes ME, Davis CS, Koch GG. Categorical data analysis using the SAS system. Cary NC, SAS Institute, 1995, pp 172-175
19. Pirovino M, Lydick E, Grob PJ, Arrenbrecht S, Altorfer J, Schmid M: Pneumococcal vaccination: the response of patients with alcoholic liver cirrhosis. Hepatology 4:946-949, 1984
20. Keeffe EB, Iwarson S, McMahon BJ, Lindsay KL, Koff RS, Manns M, Baumgarten R, Wiese M, Fourneau M, Safary A, Clemens R, Krause DS: Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology 27:881-886, 1998
21. Arguedas MR, Johnson A, Eloubeidi MA, Fallon MB: Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients. Hepatology 34:28-31, 2001
22. Keeffe EB, Krause DS: Hepatitis B vaccination of patients with chronic liver disease. Liver Transpl Surg 4:437-439, 1998
23. Lee SD, Chan CY, Yu MI, Lu RH, Chang FY, Lo KJ: Hepatitis B vaccination in patients with chronic hepatitis C. J Med Virol 59:463-468, 1999
24. Rosman AS, Basu P, Galvin K, Lieber CS: Efficacy of a high and accelerated dose of hepatitis B vaccine in alcoholic patients: a randomized clinical trial. Am J Med 103:217-222, 1997
25. Dumot JA, Barnes DS, Younossi Z, Gordon SM, Avery RK, Domen RE, Henderson JM, Carey WD: Immunogenicity of hepatitis A vaccine in decompensated liver disease. Am J Gastroenterol 94:1601-1604, 1999
26. Van Thiel DH, el-Ashmawy L, Love K, Gavaler JS, Starzl TE: Response to hepatitis B vaccination by liver transplant candidates. Dig Dis Sci 37:1245-1249, 1992
27. Patrick KM, Woolley FR: A cost-benefit analysis of immunization for pneumococcal pneumonia. JAMA 245:473-477, 1981
28. Turner D, Wailoo A, Nicholson K, Cooper N, Sutton A, Abrams K: Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Technol Assess 7:1-170, 2003
29. Myers RP, Gregor JC, Marotta PJ: The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C. Hepatology 31:834-839, 2000
30. Jacobs RJ, Koff RS, Meyerhoff AS: The cost effectiveness of vaccinating chronic hepatitis C patients against hepatitis A. Am J Gastroenterol 97:427-434, 2002
31. Arguedas MR, Heudebert GR, Fallon MB, Stinnett AA: The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States. Am J Gastroenterol 97:721-728, 2002
32. Jacobs RJ, Koff RS: Cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C. Hepatology 32:873-874, 2000 (letter)
33. Margolis HS, Coleman PJ, Brown RE, Mast EE, Sheingold SH, Arevalo JA: Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations. JAMA 274:1201-1208, 1995
34. Jacobs RJ, Saab S, Meyerhoff AS: The cost effectiveness of hepatitis immunization for US college students. J Am Coll Health 51:227-236, 2003
35. Armstrong GL, Bell BP: Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization. Pediatrics 109:839-845, 2002
36. Coleman PJ, McQuillan GM, Moyer LA, Lambert SB, Margolis HS: Incidence of hepatitis B virus infection in the United States, 1976-1994: estimates from the National Health and Nutrition Examination Surveys. J Infect Dis 178:954-959, 1998
37. Blostein J, Clark PA: Cost-effectiveness of pre-immunization hepatitis B screening in high risk adults. Public Health Rep 116:165-168, 2001
38. Jacobs RJ, Saab S, Meyerhoff AS, Koff RS: An economic assessment of pre-vaccination screening for hepatitis A and B. Public Health Rep 118:550-558, 2003